Explore more publications!

Health Monitor Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Malta.

Press releases published on February 5, 2026

Blueprint for Action Calls for Pan-Canadian Leadership to Close the Women’s Health Gap
Le plan d’action Diriger pour combler l’écart demande aux acteurs au pouvoir partout au pays de réduire les disparités en matière de santé des femmes
Serotonin Anti-Aging Center to Open Lake Nona Location This Spring, Expanding Orlando Presence
Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant
Continuing a 50-Year Legacy: Drs. Randy Viola, Thomas Hackett, David Kuppersmith, Leslie Vidal and Sonny Gill to Represent Team USA in Medical Roles at 2026 Olympic Winter Games in Italy
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
Proven Senior Care Model Takes Center Stage at the Capitol
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year
In a Defining Election Year, MAPS Releases Policy Guidebook to Shape the Future of Psychedelic Reform
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions